Patent holdings for IPC class A61K 31/325

Total number of patents in this class: 405

10-year publication summary

36
35
32
41
32
32
25
25
16
21
2016 2017 2018 2019 2020 2021 2022 2023 2024 2025

Principal owners for this class

Owner
All patents
This class
Axsome Malta Ltd.
76
21
SK Biopharmaceuticals Co., Ltd.
265
16
Osmotica Kereskedelmi ES Szolgaltato Kft
23
14
Arena Pharmaceuticals, Inc.
362
12
Bio-Pharm Solutions Co., Ltd.
60
12
Ovid Therapeutics Inc
167
11
The Regents of the University of California
20195
8
University of Tennessee Research Foundation
755
6
Yissum Research Development Company of The Hebrew University of Jerusalem Ltd.
1345
6
Takeda Pharmaceutical Company Limited
2707
5
Italfarmaco SpA
148
5
Dompé Farmaceutici S.p.A.
273
4
Enanta Pharmaceuticals, Inc.
433
4
SK Chemicals Co., Ltd.
617
4
Universita' degli Studi di Milano
237
4
Azura Ophthalmics Ltd.
75
4
Theramex HQ UK Limited
93
4
Pelli Skin Co., LLC
11
4
The Procter & Gamble Company
22003
3
Janssen Pharmaceutica N.V.
3360
3
Other owners 255